Learning Objectives
- Demonstrate an increase in the learner’s knowledge of clinical medicine.
- Demonstrate an improvement in the learner’s ability to make decisions that provide safe and effective medical care.
- Recognize areas of personal strength and areas for growth in clinical knowledge.
Intended Audience
Physicians and residents who are seeking to maintain and augment their knowledge in clinical medicine and/or preparing for their initial board certification or recertification.
Accreditation
The Massachusetts Medical Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Massachusetts Medical Society designates this enduring material for a maximum of 270 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
AAPA Credit Designation Statement
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 270 hours of Category 1 credit for completing this program.
ABIM MOC Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 270 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Method of Participation
You must answer questions correctly to receive CME credit and MOC points.
Six questions answered correctly are designated for 1 AMA PRA Category 1 Credit™.
Six questions answered correctly equal 1 MOC point.
Accreditation Term:
CME credit and MOC points are available for 3 years. Term begins January 27, 2017.
Original Release Date: January 27, 2014
Review dates: 2015, 2016
Expiration Date: January 27, 2020
Individual Disclosures
During their tenure with NEJM Knowledge+, the following planners, authors, and reviewers have disclosed the following relevant financial relationships with an ACCME-defined commercial interest.
Thomas M. Best, MD, PhD
– Consultant for Abbot and ZetrOZ
William Busse, MD
– Advisory board for Merck
– Consultant for Amgen, Novartis, GlaxoSmithKline, MedImmune, and Genentech
– Data monitoring boards for Genentech and Boston Scientific
– Study oversight committee for ICON
Andrew T. Chan, MD
– Consultant for Bayer Healthcare, Pfizer, Pozen, and Millennium Pharmaceuticals
– Speakers bureau for Millennium Pharmaceuticals
Vincent W. Chiang, MD
– Financial interest in AugMI Labs
Jean M. Connors, MD
– Honoraria from Pfizer
– Consultant for Proteostasis Therapeutics
– Scientific advisory board for Portola Pharmaceuticals
Kelly M. Cordoro, MD
– Consulting for Anacor Pharmaceuticals
Rajesh T. Gandhi, MD
– Scientific advisory board for Gilead
– Grant support from Tibotec (Janssen Therapeutics), Abbott, ViiV Healthcare, Gilead, and Merck
– Consultant for Theratechnologies
James E. Gern, MD
– Consultant for Janssen Pharmaceutical Companies of Johnson & Johnson, GlaxoSmithKline, Boehringer Ingelheim, MedImmune AstraZeneca, and Merck
– Grant support from GlaxoSmithKline and Merck
Emily M. Godfrey, MD, MPH
– Speakers’ bureaus for Merck Pharmaceuticals and Bayer Women’s Health
– Consultant for Teva Women’s Health
Jason Robert Gotlib, MD
– Clinical trial research funding from Novartis, Promedior, Incyte, CTI Biopharma, Gilead, Seattle Genetics, and Pharmacyclics
– Study steering committee member, advisory board member, and receipt of honoraria from Novartis
– Advisory board member and receipt of honoraria from Incyte
Elizabeth Harrison, MD
– Financial interest in Pfizer, Merck, and Express Scripts
Simon M. Helfgott, MD
– Consultant for AbbVie and Genentech
James V. Hennessey, MD
– Consultant for Akrimax and AbbVie
Mihir M. Kamdar, MD
– Scientific advisory board for Amorsa Therapeutics
– Expert advisory panel for Collegium Pharmaceuticals
Amel Karaa, MD
– Consulting fees from Akros Pharma, Concert, Alexion, Lumleian, and Mitobridge
– Grant support, reimbursement for travel, and consulting payments from Stealth BioTherapeutics and Shire
– Grant support, consulting fees, reimbursement for travel, and honoraria from Sanofi Genzyme
– Grant support and reimbursement for travel from Reata Pharmaceuticals and Protalix BioTherapeutics
Eli Miloslavsky, MD
– Fellowship in 2012–2013 from Genentech
Paul A. Monach, MD
– Grant support from Genentech
Christopher J. Moran, MD
– Grant support from Allergan
Alan C. Moss, MD
– Consultant for Janssen Pharmaceutical Companies of Johnson & Johnson, Theravance Biopharma, Seres Therapeutics, Boehringer Ingelheim, Pfizer, Gilead, and Mallinckrodt Pharmaceuticals
– Grant research/support from Pfizer and Boehringer Ingelheim
Leigh C. Reardon, MD
– Consultant and speakers bureau for Actelion
Misha A. Rosenbach, MD
– Consultant for Celgene
Paul E. Sax, MD
– Consultant for Bristol-Myers Squibb, GlaxoSmithKline, Merck, Janssen Pharmaceutical Companies of Johnson & Johnson, and Gilead
– Grant support from Bristol-Myers Squibb, GlaxoSmithKline, Merck, and Gilead
Marvin I. Schwarz, MD
– Consultant for Boehringer Ingleheim, InterMune, and Merck
Bradford Shingleton, MD
– Consultant for Transcend Medical
– Grant research/support from Alcon
John I. Takayama, MD, MPH
– Financial interest in Omnicell
Derrick J. Todd, MD, PhD
– Consultant for Genentech and Regeneron
Avram Z. Traum, MD
– Consultant for Alexion Pharmaceuticals
Andrew A. Wagner, MD
– Consultant for BK ultrasound
James L. Zehnder, MD
– Grant research/support from Novartis
None of the other individuals in a position to control the activity have any relevant financial relationships with commercial interests to report. The complete list of contributors can be found here.
Conflict of Interest Resolution
The Department of Continuing Education and Certification (DCEC) of the Massachusetts Medical Society has reviewed the appropriate documentation provided by the above planners, authors, and reviewers. Any potential conflicts of interest have been identified and resolved using DCEC processes for conflict management and resolution. For more information about DCEC processes for COI management, please contact the DCEC at continuingeducation@mms.org.
Disclosure of Commercial Support
No commercial support was received for this activity.
Medium or Combination of Media Used
This is an adaptive self-assessment tool designed to adjust to the learner’s strengths and areas for growth, and can be accessed from a desktop, laptop, tablet, or smartphone. Learners choose the subspecialty area and are presented with a sequence of questions. After each question is answered, the user is provided with the key learning point, detailed feedback that discusses the correct answer as well as each of the wrong answers, and citations to relevant articles.
Estimated Time to Complete the Educational Activity
One hour for every 6 questions answered correctly.
Bibliography
Each clinical vignette includes citations and references.
Hardware/Software Requirements
Windows
- Google Chrome 30+, Safari 5.0+, Internet Explorer 11.0+, Mozilla Firefox 10.0+, Microsoft Edge
Recommended: Google Chrome 39+, Safari 7+, Internet Explorer 11, or Firefox 32+ - Windows 7 (32-bit and 64-bit), Windows 8+. Windows 7+ is recommended.
- Minimum 1 GB of RAM but 2 GB or greater is recommended
- 2.33 GHz or faster x86-compatible processor, or Intel® Atom™ 1.6 GHz or faster processor for netbooks
- Display resolution: 1024 × 768 or better
Mac OS
- Google Chrome 14+, Safari 5.0+, Mozilla Firefox 12.0+
Recommended: Google Chrome 39+, Safari 7+, or Firefox 32+ - Mac OS X v10.6+
- Minimum 1 GB of RAM but 2 GB or greater is recommended
- Intel Core™ Duo 1.33GHz or faster processor
- Display resolution: 1024 × 768 or better
Mobile/Tablet
NEJM Knowledge+ apps are available for iOS and Android smartphones and tablets; Android phones may access NEJM Knowledge+ through our mobile-optimized browser version.
- iOS devices running OS 7+(includes iPhone and iPad devices). iOS version 8+ is recommended.
- Android version 4+ (includes smartphones and tablets). Android version 5+ is recommended. Note: Android phones will also support the browser version of each product (Chrome recommended).
Contact Information
For all questions and comments, please contact NEJM Knowledge+ by email at knowledgeplussupport@nejm.org or call toll-free 855-318-9303 (within the USA and Canada) or 781-434-7998.
Policy on Privacy and Confidentiality
Read our Privacy Policy.
Copyright
Copyright information can be found in the NEJM Group Terms of Use.
ABIM Policy
Participant data is governed by ABIM’s Confidentiality Policy and submitted to the ABIM using the ACCME PARS system. Identifiable patient data shall not be provided to ACCME or ABIM by any organization or participant.
Public Information About Providers of MOC Activities
The following information, provided to ACCME by the provider, is considered public information, and therefore may be released by ABIM and/or ACCME.
- Activity title
- Activity type
- Accredited provider name
- Accredited provider contact information (including phone number and website address)
- Joint provider name (if applicable)
- Activity date (start date, in the case of a multi-day live activity or enduring material activity)
- Specialty(ies) activity addresses
- Maximum allowable MOC points and patient safety credit awarded
The following information will be made available in physicians’ MOC history reports located in the secure physician login area of ABIM’s website:
- Activity title
- MOC point value, including patient safety credit, if applicable
- Activity completion date
